Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged 65 and Over in England and Wales

Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged 65 and Over in England and Wales

Background: Invasive Pneumococcal Disease (IPD) is a major public health concern. The effectiveness of 23-valent polysaccharide pneumococcal vaccine (PPV23) against IPD in older age-groups is not fully understood. We measured PPV23 effectiveness against IPD and interpreted changes in IPD incidence b...

Full description

Bibliographic Details
Main Authors:	Abdelmajid Djennad, Mary E. Ramsay, Richard Pebody, Norman K. Fry, Carmen Sheppard, Shamez N. Ladhani, Nick J. Andrews
Format:	Article
Language:	English
Published:	Elsevier 2018-12-01
Series:	EClinicalMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589537018300622

Similar Items

Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000–June 30, 2016
by: Godwin Oligbu, et al.
Published: (2019-09-01)

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
by: Shamez N. Ladhani, et al.
Published: (2013-01-01)

Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and Wales.
by: Nick Andrews, et al.
Published: (2011-01-01)

Rapid Spread of Pneumococcal Nonvaccine Serotype 7C Previously Associated with Vaccine Serotype 19F, England and Wales
by: Ashley Makwana, et al.
Published: (2018-10-01)

Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England.
by: Jo Southern, et al.
Published: (2018-01-01)

7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?
by: Yoon Hong Choi, et al.
Published: (2011-01-01)

Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study.
by: Yoon Hong Choi, et al.
Published: (2019-07-01)

Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England.
by: Albert Jan van Hoek, et al.
Published: (2016-01-01)

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study.
by: Hannah Lawrence, et al.
Published: (2020-10-01)

Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013–2017
by: Reiko Shimbashi, et al.
Published: (2020-10-01)

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
by: Salsench Elisabet, et al.
Published: (2010-03-01)

The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Rheumatoid Arthritis
by: M. S. Naumtseva, et al.
Published: (2015-08-01)

Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in Brazilian elderly
by: V. Simonsen, et al.
Published: (2005-02-01)

EFFICACY AND SAFETY OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: M. S. Naumtseva, et al.
Published: (2015-05-01)

Efficacy of combined influenza and 23-valent pneumococcal polysaccharide vaccines in chronic smokers
by: Li, Tsz-wai, et al.
Published: (2014)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
by: Anna M.M. van Deursen, et al.
Published: (2012-11-01)

Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.
by: Gerhard Falkenhorst, et al.
Published: (2017-01-01)

Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly.
by: Irina Kislaya, et al.
Published: (2019-01-01)

Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in Japan.
by: Shu-ling Hoshi, et al.
Published: (2015-01-01)

Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
by: Stubbs Liz, et al.
Published: (2009-08-01)

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: V. K. Tatochenko, et al.
Published: (2012-03-01)

Pneumococcal Pneumonia and Invasive Pneumococcal Disease in Those 65 and Older: Rates of Detection, Risk Factors, Vaccine Effectiveness, Hospitalisation and Mortality
by: Roger E. Thomas
Published: (2021-02-01)

Impact of Pneumococcal Conjugate Vaccine Thirteen Valent on the Reduction of Invasive Pneumococcal Disease
by: Coulibaly, Aissata
Published: (2016)

Safety and efficacy of 23-valent polysaccharide pneumococcal vaccine in patients with systemic lupus erythematosus
by: G. M. Tarasova, et al.
Published: (2021-06-01)

ASSESSMENT OF THE IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATIC DISEASES
by: M. S. Naumtseva, et al.
Published: (2016-02-01)

Reduction of free polysaccharide contamination in the production of a 15-valent pneumococcal conjugate vaccine.
by: Yoon Hee Whang, et al.
Published: (2020-01-01)

Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)
by: Anderson, A.S, et al.
Published: (2022)

Direct effect of 10-valent conjugate pneumococcal vaccination on pneumococcal carriage in children Brazil.
by: Ana Lucia Andrade, et al.
Published: (2014-01-01)

Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine.
by: Carina Valente, et al.
Published: (2012-01-01)

Estimating age-stratified influenza-associated invasive pneumococcal disease in England: A time-series model based on population surveillance data.
by: Chiara Chiavenna, et al.
Published: (2019-06-01)

13-valent pneumococcal conjugate vaccine in Africa
by: Robert Cohen, et al.
Published: (2017-03-01)

Effect of 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) Administrated to Elderly Cancer Patients
by: Wen-YenChiou, et al.
Published: (2018)

INVESTIGATION OF IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: G. M. Tarasova, et al.
Published: (2018-09-01)

Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for S. pneumoniae
by: Allison E.B. Turner, et al.
Published: (2017-03-01)

23-Valent Pneumococcal Polysaccharide Vaccine Uptake in the United States Air Force HIV Program
by: Thad F. Ocampo MD, et al.
Published: (2016-07-01)

Multiple colonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal polysaccharide vaccine.
by: Silvio D Brugger, et al.
Published: (2010-07-01)

Pneumococcal conjugate 7-valent vacciPNEUMOCOCCAL CONJUGATE 7-VALENT VACCINE IN CHILDREN. REGIONAL EXPERIENCEne in children. Regional experience
by: N. L. Chernaya, et al.
Published: (2012-02-01)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
by: Bhavna Dhingra, et al.
Published: (2020-12-01)

PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
by: N. L. Chernaya, et al.
Published: (2013-01-01)

Pneumococcal serotypes causing pneumonia in the 13 valent pneumococcal conjugate vaccine era in Australian children
by: R. Strachan, et al.
Published: (2020-12-01)